Pharmabiz

Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies

Orca Bio’s Orca-Q receives US FDA’s RMAT designation for treatment of high-risk hematologic malignancies: Menlo Park, California Orca ...
Pharmabiz

Lilly supports Haryana State-FDA action on counterfeits, reiterates sourcing via authorised channels on valid prescription

Lilly supports Haryana State-FDA action on counterfeits, reiterates sourcing via authorised channels on valid prescription: ...
Pharmabiz

Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma

Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...
Pharmabiz

Pfizer reaches settlement agreements with Dexcel Pharma, Hikma Pharma & Cipla for infringement of patents relating to Vyndamax

Pfizer Inc. announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the US District ...
Pharmabiz

Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore

Syngene PAT before exceptional items slips in Q3 by 16%, revenue up 2% to Rs. 1,037 crore: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:30 Hrs [IST] Syngene International, I ...
Pharmabiz

US FDA grants priority review to BeOne Medicines’ sBLA for Tevimbra in first-line HER2+ GEA

US FDA grants priority review to BeOne Medicines’ sBLA for Tevimbra in first-line HER2+ GEA: San Carlos, California Thursday, April 30, 2026, 16:00 Hrs [IST] BeOne Medicines Ltd ...
Pharmabiz

Leaps by Bayer and BCG: New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing

New study highlights societal optimism toward breakthrough science, and rising anxiety about how fast the world is changing: Berlin Thursday, April 30, 202 ...
Pharmabiz

Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform

Abbott receives US FDA clearance and CE Mark for next-generation Ultreon 3.0 AI-powered coronary imaging platform: Abbott Park, Illinois Thursday, April 30, 2026, 14:00 Hrs [IST] ...
Pharmabiz

Panel asks DHR to take steps to raise own resources for ICMR

The Parliamentary Panel on Health and Family Welfare has recommended that the Department of Health Research (DHR) should strive for Medical Innovations Development Acceleration Council (MIDAC) for ...
Pharmabiz

Parliamentary Panel asks Ministry of Ayush to come up with realistic projections at BE stage

Parliamentary Panel asks Ministry of Ayush to come up with realistic projections at BE stage: Gireesh Babu, New Delhi Thursday, April 30, 2026, 08:00 Hrs [IST] Observing that the ...
Pharmabiz

Parexel adds new technology capabilities in patient safety solutions with acquisition of Vitrana

Parexel adds new technology capabilities in patient safety solutions with acquisition of Vitrana: Our Bureau, Bengaluru Thursday, April 30, 2026, 13:45 Hrs [IST] Parexel, a leadin ...
Pharmabiz

NHPC organises Heart Health Talk and Awareness Camp in association with Heartnet India

NHPC organises Heart Health Talk and Awareness Camp in association with Heartnet India: Our Bureau, Mumbai Thursday, April 30 ...